{
"id":"mk19_bb_en_f07",
"number":7,
"bookId":"en",
"legend":{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"div",
"attrs":{
},
"children":[
"HTN = hypertension; HU = Hounsfield units; K = potassium; LDST = low-dose (1-mg) dexamethasone suppression test; MACE = mild autonomous cortisol excess; NFAT = nonfunctioning adrenal tumor; PAC = plasma aldosterone concentration; PRA = plasma renin activity."
]
},
{
"type":"tag",
"tagName":"div",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"a"
]
},
"Data from Fassnacht M, Arlt W, Bancos I, et al. Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016;175:G1-34. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/27390021",
"target":"_blank"
},
"children":[
"PMID: 27390021"
]
},
" doi:10.1530/EJE-16-0467"
]
},
{
"type":"tag",
"tagName":"div",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"b"
]
},
"Refer to Table 21 in MKSAP 19 Endocrinology and Metabolism for more CT and MRI findings. If imaging is suspicious in a patient with known malignancy, biopsy should be considered to confirm adrenal metastasis after screening for pheochromocytoma is completed."
]
},
{
"type":"tag",
"tagName":"div",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"c"
]
},
"Positive screening tests usually require further biochemical evaluation to confirm the diagnosis."
]
},
{
"type":"tag",
"tagName":"div",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"d"
]
},
"Measure plasma metanephrines if radiographic appearance is typical for a pheochromocytoma; otherwise measure 24-hour urine metanephrines and catecholamines."
]
},
{
"type":"tag",
"tagName":"div",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"sup",
"attrs":{
},
"children":[
"e"
]
},
"Hormonal evaluation for an androgen-producing adrenal tumor is indicated only if clinically suspected based on the presence of hirsutism, virilization, or menstrual irregularities in women."
]
}
]
},
"title":{
"type":"tag",
"tagName":"span",
"attrs":{
},
"children":[
"Algorithm for the Initial Diagnostic Evaluation and Follow-up of an Incidentally Noted Adrenal Mass:"
]
},
"footnotes":[

],
"imageInfo":{
"hash":"8011069fda2a1a67b5a4af00754c0359",
"height":647,
"width":635,
"extension":"svg",
"vector":true
}
}